Consort Medical plc (LON:CSRT) insider Richard Cotton bought 14 shares of the business’s stock in a transaction that occurred on Friday, October 7th. The shares were bought at an average price of GBX 1,098 ($13.59) per share, with a total value of £153.72 ($190.25).

Shares of Consort Medical plc (LON:CSRT) opened at 1110.00 on Wednesday. The stock has a 50 day moving average of GBX 1,062.24 and a 200 day moving average of GBX 1,021.15. Consort Medical plc has a 12-month low of GBX 908.00 and a 12-month high of GBX 1,155.00. The company’s market cap is GBX 542.00 million.

Several equities analysts recently commented on the stock. Stifel Nicolaus reiterated a “buy” rating and set a GBX 1,200 ($14.85) target price on shares of Consort Medical plc in a research note on Thursday, June 16th. Investec increased their price objective on shares of Consort Medical plc from GBX 1,150 ($14.23) to GBX 1,170 ($14.48) and gave the company a “buy” rating in a research note on Thursday, June 16th. Panmure Gordon restated a “buy” rating and issued a GBX 1,145 ($14.17) price objective on shares of Consort Medical plc in a research note on Thursday, June 16th. Canaccord Genuity restated a “buy” rating and issued a GBX 1,300 ($16.09) price objective on shares of Consort Medical plc in a research note on Thursday, August 11th. Finally, Numis Securities Ltd restated an “under review” rating on shares of Consort Medical plc in a research note on Friday, June 17th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of GBX 1,149.67 ($14.23).

About Consort Medical plc

Consort Medical plc is a contract development and manufacturing organization (CDMO). The Company is engaged in providing delivery technologies, formulation and manufacturing solutions for drugs. The Company operates through two divisions: Bespak and Aesica. The Bespak division develops and manufactures drug delivery devices to deliver drugs to sufferers of asthma and chronic obstructive pulmonary disease (COPD).

Receive News & Stock Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related stocks with our FREE daily email newsletter.